Antibiotics · 2020 · 32 citations · 33 references
the decrease and better use of carbapenems achieved could have clinical and ecological impact over five years, reduce inpatient days, hospital-acquired MDR BSIs, and candidemia, despite the increase in other antibiotic-consumption.
33
R. Phillip Dellinger, Mitchell M. Levy, Andrew Rhodes et al. · Critical Care Medicine · 2013 · 9.7K citations
Critical Care Management, Critical Care Medicine, Severe Sepsis +13
Evelina Tacconelli, Elena Carrara, Alessia Savoldi et al. · The Lancet Infectious Diseases · 2017 · 5.8K citations
Bacterial Resistance, Antimicrobial Drug Discovery, Antimicrobial Susceptibility +14
Thomas Sochacki, Frédéric Jourdain, Yvon Perrin et al. · Eurosurveillance · 2016 · 747 citations · Full text
Mainland France, Virus Epidemiology, Epidemiological Dynamic +16
David van Duin, César A. Arias, Lauren Komarow et al. · The Lancet Infectious Diseases · 2020 · 313 citations · Full text
Clinical Epidemiology, Pharmacology, Carbapenem-resistant Enterobacterales +7